Scrip
Sanofi-Aventis signs cancer deal with Micromet
29 October 2009
Simon Varcoe
Please Login to read the full article.
29 October 2009
Simon Varcoe
Sanofi-Aventis is to pay Micromet €8 million upfront as part of a global licensing agreement for the development of a BiTE antibody against an antigen present in carcinoma cells.
BiTE antibodies may help to bind T-cells to tumour cells, which ultimately induces the tumour cell to self-destruct.
Micromet...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
